Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Thyroid Neoplasms × selpercatinib × Clear all

Status

Sponsor Class

Study Type

Interventional 6 Observational 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Sexual Dysfunction, Physiological 1 Eunuchism 1 Erectile Dysfunction 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Thyroidectomy 5 Iodine-131 5 lenvatinib 2 anlotinib 2 Ultrasonography 2 Surgical Procedures, Operative 2 Sorafenib 2 Interviews as Topic 2 Focus Groups 2 Biopsy, Fine-Needle 2 trastuzumab deruxtecan 1 trametinib 1 selpercatinib 1 pralsetinib 1 pembrolizumab 1 gallium Ga 68 dotatate 1 dabrafenib 1 Triiodothyronine 1 Transurethral Resection of Prostate 1 Thyroxine 1 Thyrotropin Alfa 1 Surveys and Questionnaires 1 Routinely Collected Health Data 1 Nivolumab 1 Molecular Diagnostic Techniques 1 Minimally Invasive Surgical Procedures 1 Lymph Node Excision 1 Iodine-124 1 Iodine-123 1 Immunohistochemistry 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07419932 2026-02-19

NeoLATC

Fujian Medical University

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡